Conference abstractPublished 2016
Allosteric receptor-receptor interactions in heteroreceptor complexes give a new dimension to molecular neuroscience
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The biological principle of formation of homo and heteroreceptor complexes with allosteric receptor-receptor interactions including GPCR-GPCR, GPCR-Ion Channel Receptor and GPCR-RTK heteroreceptor complexes appears to be accepted. This takes place through direct physical interactions through homomerization or heteromerization involving also sets of plasma membrane-associated adapter proteins and can include e.g., ion channels and transmitter transporters. The heteromerization alters receptor protomer recognition, signaling and trafficking and thus their pharmacology and function. One emerging new concept in molecular neuropharmacology is that a dysfunction or disruption of allosteric receptor-receptor interactions with formation of novel heteroreceptor complexes contributes to disease preogression in the CNS including addiction. They form major integrative centers of signaling in the CNS and play an important part in learning and memory and are proposed to form molecular engrams crucial for long-term memory. The heteroreceptor complexes are new targets for neurotherapeutics in the CNS giving us a new field in molecular neuroscience. The demonstration of multiple D2 heteroreceptor complexes in ventral and dorsal striatum including A2A-D2, NTS1-D2, 5-HT2A-D2 and oxytocinR-D2 heteroreceptor complexes opened up a promised land for drug development in ParkinsonâÂ?Â?s disease, schizophrenia and drug addiction. Understanding these D2 heterocomplexes and their dysfunction in these diseases leads to new strategies for their treatment, avoiding side-effects and optimizing combined treatments. This development includes heterobivalent drugs to selectively target each heterodimer. Also, the discovery of many 5-HT1A heteroreceptor complexes, like the FGFR1-5-HT1A heterocomplex, of high dynamics opens up new understanding of the molecular basis of neuroplasticity and its relevance for depression.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroscience and Neuropharmacology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Kjell Fuxe”
